Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Impact of Transcatheter Aortic Valve Implantation (TAVI) on the Gut Microbiota in Patients With Aortic Valve Stenosis

NCT07052071 is registered in ClinicalTrials.gov with Hippocration General Hospital as lead sponsor.

NCT NCT07052071
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07052071 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Impact of Transcatheter Aortic Valve Implantation (TAVI) on the Gut Microbiota in Patients With Aortic Valve Stenosis
Lead sponsor
Hippocration General Hospital
Phase
Observational
Overall status
Recruiting
Start date
September 1, 2025
Completion date
November 1, 2027
Enrollment
40 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

aortic stenosis, gut microbiome, gut microbiota, tavi, tavi(transcatheter aortic valve implantation)